Trending News Today: Some of Most Common, Deadliest Cancer Types Underfunded

A new Northwestern Medicine study found that many of the deadliest or most common cancers receive the least amount of nonprofit research funding, according to a press release. The study, which is the first to compare nonprofit funding distribution in the United States across cancer types, showed that colon, endometrial, liver and bile duct, cervical, ovarian, pancreatic, and lung cancers were all poorly funded despite their high incidences. In contrast, breast cancer, leukemia, lymphoma, and pediatric cancers were all well-funded, according to the findings.
A recent study suggests that cannabis use may be linked to memory deficits or difficulties with cognitive function, Reuters reported. According to the article, 1121 study participants were interviewed about any history of drug use, tested for evidence of use, and then underwent neuropsychological evaluations. Overall, participants who had tested positive for tetrahydrocannabinol scored worse on tests of so-called episodic memory and of mental processing speed, the article reported.  
A new assessment model may help predict venous thromboembolism (VTE) in patients with multiple myeloma who are being treated with immunomodulatory drugs, The American Journal of Managed Care reported. According to the article, the researchers studied 2397 patients from the Surveillance, Epidemiology and End Results registries and linked Medicare databases, as well as 1251 patients from the Veterans Health Administration. Overall, the researchers identified 5 common risk factors: a prior history of VTE, surgery within 90 days, being 80 years of age or older, high steroid dose, and non-Asian race.

Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 

Related Articles

Moderate physical activity may improve progression-free survival and reduce treatment-related adverse effects in patients undergoing chemotherapy for advanced colorectal cancer.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.